Table 3. Mammalian adaptation markers (Mertens et al., 2013) in the amino acid sequences of Av1955.
Mammalian adapt. marker mutation | Amino acid at the marker siteb | Phenotypec | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
Isolates in 2013–2014d | Viruses with the highest identityd | |||||||||
Protein | Mutationa | Av39 | Av240 | Av154 | Eg20616 | Av1210 | Spg119 | Av1534 | Av1955 | |
PB2 | T63I | I | I | I | I | I | I | I | I | [1] |
L89V | V | V | V | V | V | V | V | V | [1], [2] | |
G309D | D | D | D | D | D | D | D | D | [1], [2] | |
R318K | R | R | R | R | R | R | R | K | [2] | |
T339K | K | T | T | A | T | K | T | K | [1], [2] | |
Q368R | R | R | Q | R | Q | R | Q | R | [1], [2] | |
H447Q | Q | Q | Q | Q | Q | Q | Q | Q | [1], [2] | |
R477G | G | G | G | G | G | G | G | G | [1], [2] | |
I495V | V | V | V | V | V | V | V | V | [1], [2] | |
K526R | K | R | K | R | K | K | K | K | [2], [3] | |
V667I | I | V | V | V | V | V | V | V | [4] | |
A676T | T | T | T | T | T | T | T | T | [2], [3] | |
K702R | R | K | K | K | K | R | K | R | [4] | |
Subtotal | 11 | 9 | 6 | 10 | 7 | 10 | 6 | 11 | ||
PB1 | A3V | V | V | V | V | V | V | V | V | [1], [2] |
L13P | P | P | P | P | P | P | P | P | [1], [2], [5] | |
R207K | K | R | K | K | K | K | K | K | [2] | |
K328N | N | N | N | N | N | N | N | N | [2] | |
S375N | N | N | N | N | N | S | N | N | [1], [2], [5] | |
H436Y | Y | Y | Y | Y | Y | Y | Y | Y | [1], [2] | |
L473V | V | V | V | V | V | V | V | V | [2] | |
M677T | T | T | T | T | T | T | T | T | [1] | |
Subtotal | 8 | 7 | 8 | 8 | 8 | 7 | 8 | 8 | ||
PA | H266R | R | R | R | R | R | R | R | R | [2], [3] |
A404S | A | A | S | S | S | S | S | S | [5] | |
S/A515T | T | T | T | T | T | T | T | T | [2], [3] | |
Subtotal | 2 | 2 | 3 | 3 | 3 | 3 | 3 | 3 | ||
HA | D94N | D | S | N | N | N | N | N | N | [6], [7] |
S133A | G | S | A | A | A | A | A | A | [6] | |
Q/H/I138L/N | G | L | Q | Q | Q | Q | Q | Q | [1] | |
I151T | T | I | I | I | I | I | I | I | [6] | |
N154D | G | N | D | N | N | S | N | G | [4] | |
S155N | S | S | N | N | N | N | N | N | [2], [6] | |
T156A | T | T | A | A | A | A | A | A | [4], [6] | |
T188I | T | T | T | T | I | T | I | T | [6] | |
K189S/R | N | M | R | K | R | K | R | K | [2], [6] | |
V210I | I | V | V | V | V | V | V | V | [6] | |
A263T | S | A | T | T | T | T | T | T | [1] | |
Subtotal | 2 | 1 | 7 | 5 | 6 | 5 | 7 | 5 | ||
M1 | V15I/T | V | I | I | I | I | I | I | I | [1] |
N30D | D | D | D | D | D | D | D | D | [1] | |
T215A | A | A | A | A | A | A | A | A | [1] | |
Subtotal | 2 | 2 | 3 | 3 | 3 | 3 | 3 | 3 | ||
M2 | L55F | F | L | L | L | L | L | L | L | [4] |
Subtotal | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
NS1 | A/P42S | S | S | S | S | S | S | S | S | [1], [8] |
D87E | D | D | E | D | E | E | E | E | [1] | |
T/D92E | E | E | E | E | E | E | E | E | [1] | |
L98F | F | F | F | F | F | F | F | F | [1] | |
I101M | M | M | M | M | M | M | M | M | [1] | |
T127N | N | A | T | A | T | T | T | T | [1] | |
V149A | A | A | A | A | A | A | A | A | [1], [8] | |
N200S | S | G | D | G | S | S | G | S | [9] | |
P215T | P | P | P | P | P | P | P | T | [5] | |
Subtotal | 7 | 5 | 6 | 5 | 7 | 7 | 6 | 8 | ||
NS2 | T48A | A | A | T | A | A | A | A | A | [8] |
Subtotal | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | ||
Total | 34 | 27 | 33 | 35 | 35 | 36 | 34 | 39 |
Notes:
H5 numbering.
Bold and underlined indicate the mammalian adaptation markers. Bold, underlined, and italic indicate the mammalian adaptation markers on the genome segment donor.
[1], Pathogenic in mice, increased virulence in mammals; [2], increased polymerase activity, increased replication in mammals; [3], increased virulence in mammals and birds; [4], enhanced transmission, airborne transmissibility in mammals; [5], human host marker; mammalian host marker; [6], increased virus binding to α2,6; [7], enhanced virus fusion; [8], antagonism of IFN induction, escape of antiviral host response; [9], decreased IFN antagonism.
Virus short name: See Table 1 note.